EMV 3.27% $2.05 emvision medical devices ltd

Low cash burn and good progress made with the start of the...

  1. 2,261 Posts.
    lightbulb Created with Sketch. 388
    Low cash burn and good progress made with the start of the Pivotal Trial.

    Particularly liked the “high levels of performance” demonstrated by both Gen1 & Gen2 devices in benchtop experiments. Obviously done on phantoms but using complex simulations probably designed to test various stroke sizes, types and locations.

    Looking forward to further progress reports throughout the quarter. Well done to the team!!
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.